Immunocore Holdings plc

Immunocore Holdings plcverified

IMCR

Price:

$28.96

Market Cap:

$1.47B

Immunocore Holdings plc, a biotechnology firm established in 1999 and based in Abingdon, United Kingdom, has reached the commercial stage in its mission to create pioneering immunotherapies. The company's development pipeline addresses a range of serious conditions, including various cancers, infectious diseases, and autoimmune disorders. Its currently marketed product, KIMMTRAK, offers a treatment option for patients with uveal melanoma that is either unresectable or has metastasized. Within oncology, Immunocore is progressing IMC-C103C through early-stage (Phase I/II) dose escalation trials for several solid tumor types, notably non-small-cell lung (NSCLC), gastric, head and neck, ovarian,...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

IMCR

The Enterprise Value as of June 2026 (TTM) for Immunocore Holdings plc (IMCR) is 1.06B

According to Immunocore Holdings plc’s latest financial reports and current stock price. The company's current Enterprise Value is 1.06B. This represents a change of -20.58% compared to the average of 1.34B of the last 4 quarters.

Immunocore Holdings plc (IMCR) Historical Enterprise Value (quarterly & annually)

How has IMCR Enterprise Value performed in the past?

The mean historical Enterprise Value of Immunocore Holdings plc over the last ten years is 1.03B. The current 1.06B Enterprise Value has changed 10.16% with respect to the historical average. Over the past ten years (40 quarters), IMCR's Enterprise Value was at its highest in in the March 2019 quarter at 7.08B. The Enterprise Value was at its lowest in in the June 2019 quarter at 0.

Quarterly (TTM)
Annual

Average

1.03B

Median

886.43M

Minimum

-48579171.28

Maximum

2.34B

Immunocore Holdings plc (IMCR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immunocore Holdings plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 6.83%

Maximum Annual Enterprise Value = 2.34B

Minimum Annual Increase = -124.33%

Minimum Annual Enterprise Value = -48579171.28

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20251.32B-8.84%
20241.45B-38.03%
20232.34B27.61%
20221.84B118.55%
2021839.97M-6.94%
2020902.61M3.72%
2019870.25M6.23%
2018819.20M6.83%
201711.82M-124.33%
2016-48579171.28-77.92%

Immunocore Holdings plc (IMCR) Average Enterprise Value

How has IMCR Enterprise Value performed in the past?

The current Enterprise Value of Immunocore Holdings plc (IMCR) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

1.71B

5-year avg

1.56B

10-year avg

1.03B

Immunocore Holdings plc (IMCR) Enterprise Value vs. Peers

How is IMCR’s Enterprise Value compared to its peers?

Immunocore Holdings plc’s Enterprise Value is less than Xeris Biopharma Holdings, Inc. (1.10B), greater than Janux Therapeutics, Inc. (796.69M), less than Vera Therapeutics, Inc. (2.42B), less than Celldex Therapeutics, Inc. (2.05B), less than AbCellera Biologics Inc. (1.66B), less than Sionna Therapeutics, Inc. (1.57B), less than Harmony Biosciences Holdings, Inc. (1.61B), less than Biohaven Ltd. (1.21B), less than MannKind Corporation (1.51B), less than Nuvation Bio Inc. (1.59B),

Build a custom stock screener for Immunocore Holdings plc (IMCR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immunocore Holdings plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immunocore Holdings plc (IMCR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immunocore Holdings plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Immunocore Holdings plc's Enterprise Value?

What is the highest Enterprise Value for Immunocore Holdings plc (IMCR)?

What is the 3-year average Enterprise Value for Immunocore Holdings plc (IMCR)?

What is the 5-year average Enterprise Value for Immunocore Holdings plc (IMCR)?

How does the current Enterprise Value for Immunocore Holdings plc (IMCR) compare to its historical average?